Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolios
Close

Pharma Reaserch Products Co Ltd (214450)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
137,700 +400    +0.29%
07:40:00 - Closed. Currency in KRW ( Disclaimer )
  • Volume: 322,564
  • Bid/Ask: 137,700 / 137,900
  • Day's Range: 132,400 - 140,800
Type:  Equity
Market:  South Korea
ISIN:  KR7214450009 
Pharma Reaserch Products 137,700 +400 +0.29%

214450 Balance Sheet

 
Assess the latest Pharma Reaserch Products Co Ltd balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 214450 Annual Report data, financial summaries and charts are available for Pharma Reaserch Products Co Ltd investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 256465.27 298691.27 271290.51 243666.33
Cash and Short Term Investments 160298.06 205130.15 191504.09 176919.71
Cash - - - -
Cash & Equivalents 67244.84 80252.49 68099.96 80267.17
Short Term Investments 56548.52 46724 36564 42074.85
Total Receivables, Net 35997.71 39249.83 34733.69 34589.31
Accounts Receivables - Trade, Net 31399.95 34408.71 31933.64 31834.32
Total Inventory 50232.37 49872.35 41135.57 26946.45
Prepaid Expenses 1191.22 1125.62 1387.99 1511.89
Other Current Assets, Total 8745.92 3313.33 2529.18 3698.96
Total Assets 535281.19 535094.03 503744.3 493120.24
Property/Plant/Equipment, Total - Net 123060.6 120788.57 118594.37 118710.07
Property/Plant/Equipment, Total - Gross 157139.31 153109.44 148941.77 147240.27
Accumulated Depreciation, Total -34078.72 -32320.87 -30347.39 -28530.2
Goodwill, Net 11652.27 13809.61 13809.61 13809.61
Intangibles, Net 18708.84 20896.88 21479.38 21683.72
Long Term Investments 96950.83 48440.59 45561.35 60398.13
Note Receivable - Long Term 3300.76 3554.71 1524 1574.19
Other Long Term Assets, Total 18415.47 20650.95 20933 21242.94
Other Assets, Total 127358.71 151916.06 145687.31 107498.88
Total Current Liabilities 65899.49 52505.95 49785.17 54740.11
Accounts Payable 2830.98 5769.22 8008.33 3700.77
Payable/Accrued - - - -
Accrued Expenses 974.34 1123.01 1157.39 1042.96
Notes Payable/Short Term Debt 32344.52 17382.88 17341.29 18928.93
Current Port. of LT Debt/Capital Leases 661.55 1011.46 1254.5 1513.57
Other Current liabilities, Total 29088.11 27219.38 22023.66 29553.9
Total Liabilities 73086.59 90173.89 88278.12 107514.06
Total Long Term Debt 1300.63 31811.15 32556.07 46923.89
Long Term Debt 970.72 31335.99 32069.85 46299.09
Capital Lease Obligations 329.91 475.16 486.22 624.8
Deferred Income Tax 2794.21 3234.48 3403.37 3572.26
Minority Interest 29090.96 28840.72 27188.72 28404.34
Other Liabilities, Total -58969.79 -59252.83 -41996.5 -60892.48
Total Equity 462194.6 444920.14 415466.18 385606.18
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 5160.21 5156.24 5148.28 5055.96
Additional Paid-In Capital 175427.9 174711.6 173427.68 158578.4
Retained Earnings (Accumulated Deficit) 260787.36 245422.59 218713.01 201980.94
Treasury Stock - Common -4638.4 -4638.4 -4638.4 -4638.4
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 25457.51 24268.12 22815.6 24629.27
Total Liabilities & Shareholders' Equity 535281.19 535094.03 503744.3 493120.24
Total Common Shares Outstanding 10.2 10.19 10.26 9.99
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

214450 Price Commentary

Write your thoughts about Pharma Reaserch Products Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email